-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Monsanto, a well-known agricultural biotechnology company in the United States, announced on the 24th that it rejected the $62 billion acquisition offer made by Bayer of Germany, saying that its value was significantly underestimated, but it was still open to acquisitions
.
Monsanto issued a statement on the company's website stating that the company's board of directors agreed that Bayer's proposal was incomplete and the offer was insufficient, but the company is still willing to continue constructive dialogue to assess whether a transaction can be reached to maximize shareholder benefits
.
Monsanto CEO Hugh Grant said that we have always respected Bayer, but the current proposal (Bayer's) clearly underestimates the value of Monsanto, and it cannot fully address or guarantee the potential financing risks and regulatory review risks that may be brought about by mergers and acquisitions
.
Bayer of Germany issued a statement on the 23rd, proposing to acquire Monsanto for US$62 billion at a price of US$122 per share
.
If the two companies successfully merge, it will create the world's largest supplier of seeds and agrochemicals
.
The Wall Street Journal quoted a Bayer spokesperson as saying on the 24th that the company will consider Monsanto's response
.
Reuters said that Bayer is now under pressure to raise prices, after some shareholders of the company thought that the $122 per share proposal was too high
.
Monsanto has been criticized by international environmental organizations and people for its genetically modified products
.
Anti-Monsanto protests broke out in many large cities in Europe and the United States .
In 2015, Monsanto's attempt to acquire the Swiss seed company Syngenta was rejected.
In February this year, Syngenta was acquired by ChemChina for US$43 billion
.
As of the close of the New York stock market on the 24th, Monsanto's stock price rose 3.
11% to a closing price of $109.
3 per share
.
.
Monsanto issued a statement on the company's website stating that the company's board of directors agreed that Bayer's proposal was incomplete and the offer was insufficient, but the company is still willing to continue constructive dialogue to assess whether a transaction can be reached to maximize shareholder benefits
.
Monsanto CEO Hugh Grant said that we have always respected Bayer, but the current proposal (Bayer's) clearly underestimates the value of Monsanto, and it cannot fully address or guarantee the potential financing risks and regulatory review risks that may be brought about by mergers and acquisitions
.
Bayer of Germany issued a statement on the 23rd, proposing to acquire Monsanto for US$62 billion at a price of US$122 per share
.
If the two companies successfully merge, it will create the world's largest supplier of seeds and agrochemicals
.
The Wall Street Journal quoted a Bayer spokesperson as saying on the 24th that the company will consider Monsanto's response
.
Reuters said that Bayer is now under pressure to raise prices, after some shareholders of the company thought that the $122 per share proposal was too high
.
Monsanto has been criticized by international environmental organizations and people for its genetically modified products
.
Anti-Monsanto protests broke out in many large cities in Europe and the United States .
In 2015, Monsanto's attempt to acquire the Swiss seed company Syngenta was rejected.
In February this year, Syngenta was acquired by ChemChina for US$43 billion
.
As of the close of the New York stock market on the 24th, Monsanto's stock price rose 3.
11% to a closing price of $109.
3 per share
.
